689 related articles for article (PubMed ID: 19365816)
1. TRALI risk reduction: donor and component management strategies.
Eder AF; Benjamin RJ
J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
[TBL] [Abstract][Full Text] [Related]
2. Transfusion-related acute lung injury: current concepts for the clinician.
Triulzi DJ
Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
[TBL] [Abstract][Full Text] [Related]
3. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
[TBL] [Abstract][Full Text] [Related]
4. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury.
; Bierling P; Bux J; Curtis B; Flesch B; Fung L; Lucas G; Macek M; Muniz-Diaz E; Porcelijn L; Reil A; Sachs U; Schuller R; Tsuno N; Uhrynowska M; Urbaniak S; Valentin N; Wikman A; Zupanska B
Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164
[TBL] [Abstract][Full Text] [Related]
5. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M
Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
[TBL] [Abstract][Full Text] [Related]
6. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
Kleinman S; Grossman B; Kopko P
Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
[TBL] [Abstract][Full Text] [Related]
8. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
[TBL] [Abstract][Full Text] [Related]
9. Transfusion-related acute lung injury (TRALI): a review of investigations by the National Tissue Typing Laboratory of cases reported in New Zealand since June 2004.
Dunn P; Dinesh D
N Z Med J; 2008 Jun; 121(1276):42-7. PubMed ID: 18574508
[TBL] [Abstract][Full Text] [Related]
10. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
11. AABB survey of transfusion-related acute lung injury policies and practices in the United States.
Kopko P; Silva M; Shulman I; Kleinman S
Transfusion; 2007 Sep; 47(9):1679-85. PubMed ID: 17725734
[TBL] [Abstract][Full Text] [Related]
12. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion.
Bux J
Vox Sang; 2005 Jul; 89(1):1-10. PubMed ID: 15938734
[TBL] [Abstract][Full Text] [Related]
13. Transfusion-related acute lung injury: past, present, and future.
Cherry T; Steciuk M; Reddy VV; Marques MB
Am J Clin Pathol; 2008 Feb; 129(2):287-97. PubMed ID: 18208810
[TBL] [Abstract][Full Text] [Related]
14. Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI).
Mair DC; Hirschler N; Eastlund T
Crit Care Med; 2006 May; 34(5 Suppl):S137-43. PubMed ID: 16617258
[TBL] [Abstract][Full Text] [Related]
15. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy.
Vassallo RR; Hsu S; Einarson M; Barone J; Brodsky J; Moroff G
Transfusion; 2010 Aug; 50(8):1766-77. PubMed ID: 20345569
[TBL] [Abstract][Full Text] [Related]
16. Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008.
Ozier Y; Muller JY; Mertes PM; Renaudier P; Aguilon P; Canivet N; Fabrigli P; Rebibo D; Tazerout M; Trophilme C; Willaert B; Caldani C
Transfusion; 2011 Oct; 51(10):2102-10. PubMed ID: 21382042
[TBL] [Abstract][Full Text] [Related]
17. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
Reil A; Keller-Stanislawski B; Günay S; Bux J
Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
[TBL] [Abstract][Full Text] [Related]
18. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services.
Lin Y; Saw CL; Hannach B; Goldman M
Transfusion; 2012 Mar; 52(3):567-74. PubMed ID: 21895676
[TBL] [Abstract][Full Text] [Related]
19. Patient-specific transfusion-related acute lung injury.
Muniz M; Sheldon S; Schuller RM; Young NS; Klein HG; Leitman SF; Stroncek DF
Vox Sang; 2008 Jan; 94(1):70-3. PubMed ID: 18171330
[TBL] [Abstract][Full Text] [Related]
20. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
Keller-Stanislawski B; Reil A; Günay S; Funk MB
Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
